Online Enquiry
Subscribe
Log in / New User
Retrieve Password
此页面上的内容需要较新版本的 Adobe Flash Player。
切换导航
Home
Pharma China Web Edition
Pharma China Archives
Online Databases
Subscription/Download
Event Calendar
China Pharma Providers
About Us
Location:
Home
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Feature articles
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
Full Text
Title
Subscribe to Pharma China
Online Enquiry
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
ONLINE ENQUIRY
WiCON International Group
Bellevue, WA 98007, USA
info@pharmachinaonline.com
WiCON International Co. Ltd.
Osaka, Japan
info@pharmachinaonline.com
Relate News
10/23/2024
Guangzhou Aims to Establish Itself as a Global Biopharmaceutical Hub
10/23/2024
China Recovers CNY 16B in Misused BMI Funds
10/22/2024
Bristol Ends LaNova Partnership on Claudin18.2 ADC, Eyes Potential I-M...
10/22/2024
XellSmart RaisesCNY 100M+ in Series B1 Financing for iPS-Derived Cell ...
10/21/2024
Akeso Launches Phase 1/2 Trial for Novel Bispecific Antibody Combinati...
10/21/2024
BeiGene's Secures 14th Indication in China for Tislelizumab
10/21/2024
NMPA Issues the Pilot Plan for Staged Production of Biological Product...
10/21/2024
Changing Chinese Market Dynamics Hit Merck Where It Hurts (SCRIP Citel...
10/18/2024
AstraZeneca Submits Marketing Applications for Tremelimumab and Durval...
10/18/2024
NMPA Launches Pilot Reform for Staged Production of Biologicals
10/18/2024
Recent Executive Moves
10/17/2024
MSD Files NDA for WINREVAIR (sotatercept) in China
10/17/2024
China Initiates Data Collection for the 10th Round of the National Lev...
10/17/2024
Hutchmed Announces Positive Results from Phase II SAVANNAH Trial for L...
10/16/2024
Cytokinetics and Jixing Pharma Jointly Submit Chinese NDA for Aficamte...
10/16/2024
Hengrui Resubmits BLA to the USFDA for Anti-PD-1 Antibody Camrelizumab
10/16/2024
GSK's Submits Priority Review Application for BCMA ADC in China
10/16/2024
NHSA Issues the Notice on Regulating the Management of Externally-fill...
10/16/2024
China's New Policies On Foreign Investment In Healthcare And Biotechno...
10/16/2024
China Biopharma Tracker – Q3 2024 (PharmaDJ)
10/15/2024
AstraZeneca/Daiichi's Enhertu Approved in China as First HER2-directed...
10/15/2024
BrightGene's Phase 2 Trial of BGM0504 Injection Shows Significant Weig...
10/15/2024
Eli Lilly Invests $200M to Expand Chinese Manufacturing Facility for D...
10/15/2024
China Solicits Comments on Draft Compliance Guidelines for Pharmaceuti...
10/15/2024
Review of Online Drug Sales Growth in China 2021-2023
10/11/2024
Chinese Health Insurance Premium Income Up 4.5% in 2023
10/11/2024
Recent Executive Moves
10/10/2024
QuantumPharma's Subsidiary Ailux Biologics Partners with Janssen Biote...
10/10/2024
Eli Lilly Submits Chinese NDA for Its Anti-IL23 Antibody Mirikizumab
10/10/2024
Guangdong Aims to Boost Biopharma Sector to Over CNY 1 Trillion by 202...
Page:
21
/
359
Total number of articles:
10754
:
[First]
[<<]
[19]
[20]
[21]
[22]
[23]
[>>]
[End]
News
The Market
Industry News
Regulatory News
General Health
Legal/IPR News
Product/R&D News
API/Bulk Drug News
People in the News
Other News
Top News Worldwide
FEATURE ARTICLES
Editorials
Focus Articles
Expert Opinions
Interviews
Case Studies
Company Profiles
News in Focus
Editor's Picks
GENERAL INFORMATION
TERMS & CONDITIONS OF USE
Download Info
Contact Us
Site map
|
Contact Us
|
Links
© Wicon International Group
×
Join the mailing list
We will e-mail you the most critical news and developments about China's healthcare sector, in real time and absolutely free.
name:
e-mail:
company:
submit